cdmo.directory
← Compare landing

AskBio vs Charles River Cell & Gene Therapy

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/askbio/criver

CategoryAskBioCharles River Cell & Gene Therapy
Listed sitecdmocdmo
SummaryAskBio is a clinical-stage gene therapy company developing AAV gene therapies for genetic and rare disorders, with a focus on advancing genetic technology and lowering production costs to increase patient access.Charles River provides discovery, development, and manufacturing services across the drug development continuum, including cell and gene therapy capabilities.
Services
  • AAV Manufacturing
  • Viral Vector Manufacturing
  • Process Development
  • CMC Analytical Development
  • Upstream Processing
  • Downstream Processing
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Technology Transfer
  • Formulation Development
  • Process Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Stability Testing & Storage
  • Cell-Line Development
  • Microbial Fermentation
  • Small Molecule Development & Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
Modalities
  • AAV / Viral Vector Platform
  • Gene Therapy
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Rare Disease
  • Neurology
  • Oncology
  • Immunology
  • Neurology
Locations
  • Headquarters, Durham, North Carolina, United States
  • Headquarters, United States
  • North America, North America
  • Europe, Europe
  • Asia, Asia
Certifications
  • FDA · Identifier: Fast Track Designation (AB-1009)
  • FDA · Identifier: Orphan Drug Designation (AB-1009)
  • FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: Retrogenix® platform data support
  • PMDA · Identifier: Retrogenix® platform data support
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.